C HEALTH GP (08225) announced its interim results, with a net profit of 9.496 million yuan, a year-on-year increase of 9.16%.

22:11 27/08/2026

China Medical Group (08225) announced its interim results for 2026, with operating revenue of approximately 22.9533 million yuan, an increase of about 6.17% year-on-year. Net profit was 9.496 million yuan, demonstrating a year-on-year growth of 9.16%; earnings per share were 0.95 cents.

C HEALTH GP (08225) announced its mid-term results for 2026, with operating revenue of approximately 22.9533 million yuan, an increase of about 6.17% year-on-year. Net profit was 9.496 million yuan, up 9.16% compared to the same period last year; earnings per share were 0.95 cents.

ZHONG JI LS (00767) released its interim results, reporting a loss attributable to shareholders of HKD 6.51 million, a year-on-year decrease of 48.21%.

JINYAN KAOLIN (02693) appoints Zhu Zejian as General Manager.

JINYAN KAOLIN (02693) released its interim results, with a profit attributable to shareholders of 7.966 million yuan, a year-on-year decrease of 64.89%.

ZHONG JI LS (00767) released its interim results, reporting a loss attributable to shareholders of HKD 6.51 million, a year-on-year decrease of 48.21%.

JINYAN KAOLIN (02693) appoints Zhu Zejian as General Manager.

JINYAN KAOLIN (02693) released its interim results, with a profit attributable to shareholders of 7.966 million yuan, a year-on-year decrease of 64.89%.